Insitro Company
At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.
Investors
Connections from
Founded Date:
2018-01-01
Last Funding Type:
Series C
Headquarters:
South San Francisco, California, United States
Investors Number:
20
Employee Number:
101-250
Industry:
Medical BioTech
Last Funding Date:
2021-03-15
Funding Status:
Late Stage Venture
Total Funding:
743000000